Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?

Theodor Asgeirsson, Sen Zhang, Anthony J. Senagore

    Research output: Contribution to journalReview article

    3 Scopus citations

    Abstract

    In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

    Original languageEnglish (US)
    Pages (from-to)861-873
    Number of pages13
    JournalSurgical Oncology Clinics of North America
    Volume19
    Issue number4
    DOIs
    StatePublished - Oct 1 2010

    Keywords

    • Colon cancer
    • Follow-up
    • Rectal cancer
    • Surveillance

    ASJC Scopus subject areas

    • Surgery
    • Oncology

    Fingerprint Dive into the research topics of 'Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?'. Together they form a unique fingerprint.

  • Cite this